These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23015160)

  • 1. Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model.
    Ghosh SK; Uchida M; Yoo B; Ross AW; Gendler SJ; Gong J; Moore A; Medarova Z
    Int J Cancer; 2013 Apr; 132(8):1860-7. PubMed ID: 23015160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging.
    Medarova Z; Rashkovetsky L; Pantazopoulos P; Moore A
    Cancer Res; 2009 Feb; 69(3):1182-9. PubMed ID: 19141648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer.
    Wang P; Yoo B; Sherman S; Mukherjee P; Ross A; Pantazopoulos P; Petkova V; Farrar C; Medarova Z; Moore A
    Int J Cancer; 2016 Aug; 139(3):712-8. PubMed ID: 26996122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. uMUC1-Targeting Magnetic Resonance Imaging of Therapeutic Response in an Orthotropic Mouse Model of Colon Cancer.
    Zhao H; Richardson R; Talebloo N; Mukherjee P; Wang P; Moore A
    Mol Imaging Biol; 2019 Oct; 21(5):852-860. PubMed ID: 30793239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer.
    Moase EH; Qi W; Ishida T; Gabos Z; Longenecker BM; Zimmermann GL; Ding L; Krantz M; Allen TM
    Biochim Biophys Acta; 2001 Feb; 1510(1-2):43-55. PubMed ID: 11342146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging and deep learning analysis of uMUC1 expression in response to chemotherapy in an orthotopic model of ovarian cancer.
    Zhao H; Hayat H; Ma X; Fan D; Wang P; Moore A
    Sci Rep; 2020 Sep; 10(1):14942. PubMed ID: 32913224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal imaging probe for targeting cancer cells using uMUC-1 aptamer.
    Kang WJ; Lee J; Lee YS; Cho S; Ali BA; Al-Khedhairy AA; Heo H; Kim S
    Colloids Surf B Biointerfaces; 2015 Dec; 136():134-40. PubMed ID: 26387066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image-guided breast tumor therapy using a small interfering RNA nanodrug.
    Kumar M; Yigit M; Dai G; Moore A; Medarova Z
    Cancer Res; 2010 Oct; 70(19):7553-61. PubMed ID: 20702603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe.
    Moore A; Medarova Z; Potthast A; Dai G
    Cancer Res; 2004 Mar; 64(5):1821-7. PubMed ID: 14996745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary Cancer.
    Alberini JL; Boisgard R; Guillermet S; Siquier K; Jego B; Thézé B; Urien S; Rezaï K; Menet E; Maroy R; Dollé F; Kühnast B; Tavitian B
    Mol Imaging Biol; 2016 Aug; 18(4):617-26. PubMed ID: 26630973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
    Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
    Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice.
    Hanušová V; Caltová K; Svobodová H; Ambrož M; Skarka A; Murínová N; Králová V; Tomšík P; Skálová L
    Biomed Pharmacother; 2017 Nov; 95():828-836. PubMed ID: 28903178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers.
    Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J
    Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of MUC1 expression by glycerol guaiacolate inhibits proliferation of human breast cancer cells.
    Smith JS; Colon J; Madero-Visbal R; Isley B; Konduri SD; Baker CH
    Anticancer Agents Med Chem; 2010 Oct; 10(8):644-6650. PubMed ID: 21184665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to murine breast cancer cells modified to express MUC-1, a human breast cancer antigen, in transgenic mice tolerant to human MUC-1.
    Carr-Brendel V; Markovic D; Ferrer K; Smith M; Taylor-Papadimitriou J; Cohen EP
    Cancer Res; 2000 May; 60(9):2435-43. PubMed ID: 10811121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
    Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
    Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted doxorubicin-containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers.
    Bajo AM; Schally AV; Halmos G; Nagy A
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3742-8. PubMed ID: 14506166
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.